Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 28, 2020

SELL
$268.85 - $341.04 $2.23 Million - $2.83 Million
-8,293 Closed
0 $0
Q4 2019

Feb 21, 2020

BUY
$220.06 - $304.07 $1.16 Million - $1.61 Million
5,293 Added 176.43%
8,293 $2.46 Million
Q2 2019

Aug 19, 2019

BUY
$219.29 - $241.72 $657,870 - $725,160
3,000 New
3,000 $702,000
Q2 2018

Aug 21, 2018

SELL
$257.52 - $306.91 $500,103 - $596,019
-1,942 Closed
0 $0
Q4 2017

Mar 01, 2018

BUY
$307.64 - $344.58 $2,461 - $2,756
8 Added 0.41%
1,942 $619,000
Q3 2017

Dec 04, 2017

BUY
$281.15 - $329.69 $543,744 - $637,620
1,934
1,934 $606,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Hellman Jordan Management CO Inc Portfolio

Follow Hellman Jordan Management CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hellman Jordan Management CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hellman Jordan Management CO Inc with notifications on news.